Chapter 1. Pathogenicity and Drug resistance in Mycobacterium tuberculosis.- Chapter 1.1. Overview of tuberculosis pathogenesis.- Chapter 1.2. Response of Mycobacterium Tuberculosis to pH stress.- Chapter 1.3. Recent advances in Diagnosis of Tuberculosis.- Chapter 1.4. Molecular basis of Drug Resistance in Mycobacteria.- Chapter 1.5. Eliminating Mycobacterial persisters: novel targets for anti-TB therapy.- Chapter 1.6. Roadmap for the eradication of MDR-TB.- Chapter 2. Candida infections and therapeutic strategies.- Chapter 2.1. Fungal diseases and their treatment: a holistic approach.- Chapter 2.2. Anti-Candida therapeutics: mechanisms, resistance and safer phytomedicinal approaches.- Chapter 2.3. Mitochondria and drug resistance in Candida.- Chapter 2.4. Mechanism of Anti-Fungal for cutaneous infections: preventive potential, mechanism and treatment.- Chapter 3. Malarial parasite biology.- Chapter 3.1. Drug targets in Malarial parasites.- Chapter 3.2. Pathogenic mechanism and signaling pathways in Plasmodium.- Chapter 3.3. Mechanism of Drug Resistance in Plasmodium.- Chapter 3.4. Novel antimalarial drug targets.- Chapter 3.5. Novel therapeutic targets in malaria.- Chapter 4. Emerging Viral Diseases.- Chapter 4.1. Hepatitis C Virus and innate interferon response.- Chapter 4.1.1. Pathogen biology.- Chapter 4.1.2. Drug resistance.- Chapter 4.1.3. Novel drug targets and therapeutic strategies.- Chapter 4.2. Epidemiological trends and current challenges in Ebola.- Chapter 4.2.1. Pathogen biology.- Chapter 4.2.2.Drug resistance.- Chapter 4.2.3. Novel drug targets and therapeutic strategies.- Chapter 4.3. Prions diseases: a concern for mankind.- Chapter 5. Translational Research in Human Microbes.- Chapter 5.1. Harnessing microbiota as anti-infectives.- Chapter 5.2. Human microbiome and malignancy: principles, mechanisms and challenges.- Chapter 5.3. Current and future perspectives of nanobiotechnology: in combating microbial pathogenesis.- Chapter 5.4. Microbes in reproductive tract system: inferences from microbial world.- Chapter 5.5. miRNAs in infectious diseases.- Chapter 5.6. Application of bioinformatics in combating infectious diseases.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.